Management of subcutaneous abscesses: prospective cross-sectional study (MAGIC)
Stephen J. Chapman, Josh Burke, Jack Helliwell, Mikolaj Kowal et autres
3 citationsBritish journal of surgery
M Dyer
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
17Publications signalées
321Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Health Systems, Economic Evaluations, Quality of LifeBRCA gene mutations in cancerEconomic and Financial Impacts of CancerLung Cancer Treatments and MutationsGlioma Diagnosis and Treatment
Publications récentes
Global access to technologies to support safe and effective inguinal hernia surgery: prospective, international cohort study
Maria Picciochi, Adesoji Ademuyiwa, Adewale Adisa, Anita Eseenam Agbeko et autres
7 citationsBritish journal of surgery
Safety of maintaining elective and emergency surgery during the COVID-19 pandemic with the introduction of a Protected Elective Surgical Unit (PESU): A cross-specialty evaluation of 30-day outcomes in 9,925 patients undergoing surgery in a University Health Board
Thomas Minto, Tarig Abdelrahman, L. Jones, J Wheat et autres
4 citationsSurgery Open Science
1165P Modelling long-term survival outcomes in patients with stage (stg) IB–IIIA EGFR-mutated NSCLC from the ADAURA trial
Parneet Cheema, B. Heeg, M Dyer, Yi‐Long Wu et autres
17 citationsAnnals of Oncology
PCN449 AN ANALYSIS OF EQ-5D ADJUSTING FOR TREATMENT SWITCHING: THE CASE OF PATIENTS WITH EGFR T790M POSITIVE NSCLC TREATED WITH OSIMERTINIB
Jitendra Kumar Singh, Sandra Bourke, Louise Longworth, M Dyer et autres
0 citationsValue in Health
Cascade BRCA germline mutation (BGM) testing of women with breast (BC) or epithelial ovarian cancer (EOC) and their families with subsequent risk reducing surgery (RRS): A Canadian economics model
Paul Hoskins, A M Ecclestone, M. Hurry, M Dyer
0 citationsAnnals of Oncology
PCN356 - HOW SHOULD WE VALIDATE UTILITY MAPPING ALGORITHMS BEFORE USE? AN EXAMPLE IN NON-SMALL CELL LUNG CANCER
Joanne Gregory, M Dyer, Christopher Hoyle, Helen Mann et autres
0 citationsValue in Health
The economics of prevention in the BRCA mutation carrier: Epithelial ovarian cancer (EOC) prevention by risk-reducing surgery (RRS) is cost effective compared to treatment upon cancer development
Paul Hoskins, Anthony Eccleston, M. Hurry, M Dyer
0 citationsGynecologic Oncology
Validating The Projected Mortality Rates Used in Oncology Cost-Effectiveness Analysis: A Pitfall of Simple Benchmarking With Life Table Age-Specific Mortality Rates for A Trial Population
Y Zhang, M Dyer, Wim Vereecken
0 citationsValue in Health
Cost-Effectiveness Analysis of Testing for Brca1 and Brca2 Mutations In Women Diagnosed With Ovarian Cancer and Their Female First- And Second Degree Relatives Using A Discrete Event Simulation: A Uk Health Service Perspective
Anthony Eccleston, Anthony Bentley, M Dyer, Wim Vereecken et autres
1 citationValue in Health
Cost-Effectiveness Analysis of Testing for Brca Mutations in Women Diagnosed with Ovarian Cancer and their Female First-Degree Relatives: A Uk Health Service Perspective
M Dyer, Wim Vereecken, James Worrall, Angela George et autres
0 citationsValue in Health
Cost analysis of an integrated care model in the management of acute exacerbations of chronic obstructive pulmonary disease
Nawar Diar Bakerly, Celia Davies, M Dyer, Preet K. Dhillon
23 citationsChronic Respiratory Disease
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.